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Abstract
Associating liver partition and portal vein ligation for 
staged hepatectomy (ALPPS) is a recently introduced 
technique aimed to perform two-stage hepatectomy in 
patients with a variety of primary or secondary neoplastic 
lesions. ALPSS is based on a preliminary liver resection 
associated with ligation of the portal branch directed to 
the diseased hemiliver (DH), followed by hepatectomy 
after an interval of time in which the future liver remnant 
(FLR) hypertrophied adequately (partly because of 
preserved arterialization of the DH). Multidetector com-
puted tomography (MDCT) and magnetic resonance 
imaging (MRI) play a pivotal role in patients’ selection 
and FLR assessment before and after the procedure, as 
well as in monitoring early and late complications, as we 
aim to review in this paper. Moreover, we illustrate main 
abdominal MDCT and MRI findings related to ALPPS.
Key words: Hepatectomy; Computed tomography; 
Magnetic resonance imaging; Associating liver partition 
and portal vein ligation for staged hepatectomy; Liver 
surgery
© The Author(s) 2017. Published by Baishideng Publishing 
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Core tip: Associating liver partition and portal vein 
ligation for staged hepatectomy (ALPPS) is a variant 
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of two-stage hepatectomy aimed to obtain rapid 
hypertrophy of the future liver remnant. Given its recent 
introduction, there are still controversies on indications 
and safety issues. Cross-sectional imaging by means 
of multidetector computed tomography (MDCT) and 
magnetic resonance imaging (MRI) play a key role 
in the multidisciplinary process of patients’ selection 
and postoperative management. This review aims to 
emphasize such a role and illustrate main abdominal 
ALPPS-related findings on MDCT or MRI.
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portal vein ligation for staged hepatectomy procedure. World J 
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INTRODUCTION
Resection is the only treatment proven to achieve long-
term survival in patients with primary hepatic malig-
nancies or selected liver metastases[1,2]. Over the last 
years, advances in surgical techniques, systemic chemo-
therapy and intensive care improved the outcome of 
liver resection, leading to wider criteria for operability 
compared to the past[3]. However, adequate future liver 
remnant (FLR) (i.e., the liver remnant planned to be 
left in situ) is still a critical factor in selecting patients 
when extended hepatectomy is required, given the need 
to minimize the risk of postoperative liver failure[4,5]. 
FLR should be at least 25%-30% of the liver volume 
in patients with normal preoperative liver function, 
30% in chronic liver disease, and 40% in the setting of 
chemotherapy-related injury or cirrhosis[6,7]. Borderline 
FLR volumes pose the dilemma of whether attempting 
radical surgery vs performing palliative treatments[7].
In the 2000s, two-stage hepatectomy after pre-
operative percutaneous portal vein embolization (PVE) 
or portal vein ligation (PVL) has been proposed as a 
strategy to resect primarily inoperable tumors after 
having increased the FLR[8,9]. This approach combines 
the technical advantages of two-stage hepatectomy 
(i.e., wedge resections of lesions in the FLR in the case 
of bilobar tumors) with the compensatory hypertrophy 
of the FLR induced by PVE or PVL performed at the time 
of first surgery[10]. The mechanism with which PVE and 
PVL lead to hypertrophic FLR is complex, involving both 
the diversion of portal blood flow and release of growth 
factors[7]. Since hypertrophy usually takes at least 4 
wk to be completed, this technique shows high failure 
rate because of insufficient FLR growth and/or tumor 
progression during the interval of time between the two 
stages[11,12].
Associating liver partition and portal vein ligation for 
staged hepatectomy (ALPPS) is a two-stage hepatectomy 
procedure introduced in September 2007 by Schnitzbauer 
et al[13] to obtained more rapid and larger increase of the 
FLR volume compared to conventional staged hepatec-
tomy (40%-80% within 6-9 d vs 8%-27% within up 
to 60 d, respectively)[4,6,7,13-15]. The key technical point 
in ALPPS is the preservation of hepatic artery blood 
flow to the diseased hemiliver (DH) at the time of first 
surgical stage. Preserved arterialization leads the DH 
to act as a vital auxiliary liver and assist the growth of 
FLR through metabolic and synthetic functions[16,17]. 
ALPPS achieves a high rate of tumor complete resection 
(83%)[18], given the successful rate of adequate FLR 
growth (78%-91%)[19]. Additionally, the reduced interval 
of time between surgical steps translates into lower 
tumor progression rate, less adhesions during second 
surgery, faster patients recovery and prompter starting 
of adjuvant chemotherapy[4,15,20,21].
ALPPS is becoming increasingly popular in patients 
candidate to extended hepatectomy. To our knowledge, 
though imaging plays a key-role in planning the pro-
cedure and monitoring the results of both surgical 
stages, radiological findings related to ALPSS have been 
poorly reported. In this review, we aimed to summarize 
the current role for multidetector computed tomography 
(MDCT) and magnetic resonance imaging (MRI) in 
the procedure, which enable detailed view of pre- and 
postoperative anatomy, as well as prompt and reliable 
identification of complications. We also illustrated main 
cross-sectional imaging findings related to ALPPS, with 
special emphasis on normal aspects.
ALPSS: INDICATIONS AND TECHNIQUE
Indications
There is controversy on which lesions should be treated 
with ALPPS[6], given initially reported high mortality 
rates (up to 22% in some series)[22]. It should be kept 
in mind that ALPPS is an “extrema ratio” procedure 
to be proposed after careful, multidisciplinary patient 
selection[6,23,24]. Morbidity and mortality amount up to 
14% and 6.6% in experienced centers applying strict 
selection criteria[10,25-27]. Best results have been obtained 
in patients with bilobar metastases from colorectal cancer 
with predictable radical resection, absence of extrahepatic 
disease and partial or complete response to chemo-
therapy[2]. Other treatable lesions include hepatocellular 
carcinoma, cholangiocarcinoma (intrahepatic or hilar), 
gallbladder carcinoma, and metastases from breast 
cancer or neuroendocrine tumors[7,25,26]. However, higher 
postoperative mortality was reported for non-colorectal 
liver metastases[7]. ALPPS can be also offered as first-line 
treatment or salvage-therapy after failed PVE[20,25,28-32].
Contraindications to ALPPS include unresectable 
lesions in the FLR, unresectable extrahepatic metastases, 
infiltration of the retrohepatic avascular space, severe 
portal hypertension, high anesthesiology risk, medical 
contraindications to major hepatectomy, impossibility 
to achieve negative margins, and unresectable primary 
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tumor in extrahepatic locations[26]. ALPPS is not recco-
mended in patients with advanced liver cirrhosis, because 
liver regeneration in the context of chronic liver disease 
is less predictable[7,33]. On the other hand, some Authors 
attempted ALPPS in selected cirrhotic patients[34].
Technique
Elective indication to ALPPS is right trisectionectomy[7], 
in which FLR and DH consist of Couinaud segments 2-3 
vs 4-8 (Figures 1 and 2), respectively. Other technical 
approaches include right hepatectomy (leaving a 
segments 2-4 FLR), left hepatectomy (leaving segments 
5-8 FLR), central hepatectomy (segments 4, 5 and 8 
FLR) or monosegmental ALPPS[35-37].
ALPSS includes two consecutive surgical stages (stage 
1 and stage 2). During stage 1, the portal branch directed 
to the DH side is sectioned and sutured in order to divert 
the portal flow to the FLR. Hepatectomy is subsequently 
performed to separate the FLR from DH completely 
(complete ALPPS) or partially (partial ALPPS)[32,38]. If affected 
by metastases, the FLR is cleaned up by wedge resections 
and/or intraoperative radiofrequency ablation[17,26]. At the 
end of the procedure, DH is left in situ, often after having 
enveloped it into a hermetic bag made of plastic or a 
biodegradable type-Ⅰ acellular collagen membrane[39]. 
The rationale for using the bag is to avoid adhesions 
and obtain an easier removal of DH on surgical stage 2, 
as well as better drainage or identification of collections 
(Figures 1 and 2)[7]. The purpose of stage 1 is to 
induce hypertrophy of the FLR (in which arterial and 
portal vascular supply is preserved) and atrophy of 
the DH (in which arterial supply alone is preserved). 
Cholecystectomy is also performed[40]. In the case of 
perihilar cholangiocarcinoma, biliary continuity is obtained 
by performing Roux-en-Y bilioenteric anastomosis[26]. 
After stage 1 completion, two drains are placed along the 
transection line and within the plastic bag, respectively.
Stage 2 is scheduled 7-14 d from stage 1[2]. Hepa-
tectomy is completed by removing atrophic DH after 
transecting the serving hepatic artery, hepatic duct and 
hepatic veins (e.g., right hepatic and middle hepatic veins 
in the case of right trisectionectomy, or right hepatic vein 
only in the case of right hepatectomy).
IMAGING TECHNIQUES
First-line imaging after both surgical stages 1 and 2 is 
represented by ultrasonography (US) with Color-Doppler 
examination. In our experience, US permits a “quick-
and-dirty” evaluation at patient’s bedside to screen for 
gross complications (e.g., collections) and assess the 
patency of FLR portal vein, hepatic artery branches and 
hepatic vein. However, early postoperative US is limited 
by lack of patients’ collaboration and reduced acoustic 
DH
FLR DH FLR
DH
FLR
FLR
A B
C D
Figure 1  Scheme of trisectionectomy associating liver partition and portal vein ligation procedure. During surgical stage 1 the right portal vein is sectioned 
and sutured (arrow in A) after performing cholecystectomy (green triangle in A). Subsequently, the diseased hemiliver (DH) is sectioned from the future liver remnant 
(FLR) and wrapped with a bag (B). At the time of surgical stage 2 (C), hypertrophy of the (FLR) (blue arrowheads in D) and atrophy of the DH (arrows) have been 
obtained. Associating liver partition and portal vein ligation for staged hepatectomy procedure is then completed by removing the DH (D). 
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windows because of bowel gas and surgical dressing 
material[41]. Furthermore, US lacks panoramicity, i.e., the 
capability to represent a section or a 3D reconstruction 
of the entire liver within a single image. Consequently, 
though this technique is useful in initial diagnosis of 
liver abnormalities, it has no direct role in selecting 
patients for ALPPS (e.g., by assessing the number of 
lesions in the FLR or estimating its volume). Thus, cross-
sectional imaging with MDCT and/or MRI is mandatory 
in the preoperative patients’ selection, in evaluating 
postoperative increase in FLR volume and in assessing 
complications.
Because of wide panoramicity, fast acquisition time 
and lesser costs, MDCT should be regarded as the cross-
sectional modality of choice to image patients before and 
after ALPPS. Our institutional protocol is summarized 
in Table 1. Fast acquisition makes MDCT feasible in less 
collaborating patients, with the possibility to extend the 
examination to the thorax and/or the lower abdomen 
if needed. Moreover, the multiphasic MDCT protocol 
has the advantage of providing all-in-one evaluation of 
liver neoplasms (in terms of both tumor burden and 
characterization), extrahepatic disease or complications, 
and the status of arterial, portal and venous structures 
for the purpose of preoperative planning and com-
plications assessment. Multiplanar reformations and 3D 
reconstruction are of help in interpreting images and 
communicating imaging results to referring clinicians.
Given limited availability and longer acquisition 
times, MRI should be reserved to inconclusive MDCT 
cases, especially in the preoperative phase, i.e., when 
there is less risk of image quality degradation because 
of reduced patients’ collaboration. Similarly to other liver 
applications[41-44], MRI should be performed with 1.5 Tesla 
or 3.0 Tesla magnets, equipped with highly performing 
gradients and multi-element surface coils (preferably 
8-16 elements) implementing parallel imaging. Our MRI 
protocol is illustrated in Table 2.
Hepatobiliary contrast agents such as gadoxetic 
acid and/or gadobenate dimeglumine improve the 
detection and characterization of focal liver lesions by 
representing the vascularity and the presence/absence 
of hepatocellular contrast uptake at one time[45,46]. When 
liver metastases are the cause for ALPPS, preoperative 
MRI with diffusion-weighted imaging and hepatobiliary 
contrast agents should be regarded as the method 
of choice for detailed identification of small lesions 
potentially affecting ALPPS feasibility or FLR cleaning 
up[47]. Furthermore, hepatobiliary contrast agents are of 
help in assessing tumor relapse after surgery.
Magnetic resonance cholangiopancreatography 
(MRCP) should be used preoperatively to evaluate 
whether biliary tree anatomic variants are at risk of 
increasing surgical difficulty, or to assign the Bismuth 
category of cholangiocarcinoma extension[48]. In the 
postoperative phases, this technique can be of help 
in assessing the content of fluid collections (fluid vs 
hemorrhagic) or early and late biliary complications. In 
Figure 2  Surgical overview of the associating liver partition and portal vein ligation for staged hepatectomy procedure. A: Intraoperative findings during 
stage 1, with evidence of resection line (arrow) on the right side of ligamentum falciforme (green triangle); B: Resected liver with right hepatic vein (green triangle) and 
right hepatic artery (arrow) encircled by a vessel loop to simplify their identification during stage 2; C: After transection, diseased hemiliver is enveloped with a plastic 
bag; D: Pronounced hypertrophy of future liver remnant during intraoperative stage 2.
A B
C D
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particular, 3D T1-weighted MRCP acquired in the delayed 
phase after gadoxetic acid administration is useful in 
confirming clinical suspicion of biliary leakage (e.g., 
persisting postoperative fluid collections associated with 
clinical sign of biliary sepsis) by showing active contrast 
extravasation[44]. The presence of endobag after surgical 
stage 1 can avoid gadoxetic acid-based MRCP, since bile 
leakage can be actively monitored through the internal 
surgical drainage.
ROLE FOR IMAGING
Preoperative imaging
Preoperative findings are essential to understand whether 
ALPPS is feasible or not based on tumor burden, liver 
status and presence of ancillary findings with potential 
surgical significance. There are five main goals of cross-
sectional imaging in this setting.
The first task for imaging is accurate detection and 
characterization of liver lesions. Radiologists should 
carefully report the number, size, and location of individual 
lesions, as well as their relationship with surgically relevant 
anatomic structures, including the hepatic artery, main 
portal branches, hepatic veins, and first- to second-order 
biliary branches (Figure 3). This will help the surgeon to 
establish lesions resectability and the risk for intraopera-
tive complications (e.g., lesions close to the retrohepatic 
course of inferior vena cava, a region at higher risk of intra-
operative bleeding). Second, imaging aims to evaluate the 
status of liver parenchyma, looking for signs of cirrhosis, 
cholestasis, steatosis or any other pathologic change 
attributable to the effects of lesions, diffuse liver disease 
or chemotherapy. Liver status may influence operability, 
regardless of the FLR volume (see below). Third, it is 
crucial to identify vascular and biliary anatomy variants 
of potential surgical significance (e.g., aberrant and/or 
accessory branches)[49]. Fourth, any extrahepatic finding 
potentially affecting the feasibility of ALPPS should be 
Scan phase (timing from 
contrast injection)
Scal lenght Scanning parameters Rationale in the preoperative phase Rationale in the postoperative phases
Unenhanced Upper abdomen KVp 120
mA modulated 
between 200-450
Tube rotation 0.6 s
Pitch 0.984
Noise index 16.10
Collimation 1.25 
mm (0.625 for the 
angiographic phase)
Image reconstruction 
thickness 1.25 mm
Identifying potential confounders in 
image interpretation (e.g., lesion’s or 
vascular calcifications). Measuring 
baseline attenuation of target lesions 
(e.g., fat-containing HCC) or in 
diffuse liver disease (e.g., steatosis)
Identifying potential confounders in 
image interpretation (e.g., surgical 
clips). Measuring the attenuation of 
intra-abdominal collections (biloma vs 
hematoma)
This phase is not required if recent 
prior imaging is available.
This phase in not mandatory in repeated 
follow-up examinations
Angiographic phase (20) Upper abdomen Assessing the patency and anatomic 
variants of the hepatic artery and 
its branches, both on source images 
and MIP reconstructions
Assessing the sources of suspicious active 
postoperative bleeding
Delayed arterial (35-40 s) Upper abdomen Assessing hypervascular focal liver 
lesions (malignant and benign ones)
Assessing the patency of the hepatic artery 
and its branches. Identifying the recurrence 
of hypervascular tumors in the delayed 
post-operative period
Venous (70 s) Whole abdomen Assessing lesions’ enhancement 
pattern for the purpose of 
identification/characterization. 
Assessing the patency and 
anatomic variants of the portal 
trunk and intrahepatic branches, 
both on source images and MIP 
reconstructions. Identifying 
additional abdominal findings 
potentially contraindicating ALPSS. 
Assessing for signs of chronic liver 
disease (including splenomegaly, 
venous collaterals and ascites)
Assessing the portal status (absence of flow 
in the ligated portal branch and patency 
of the FLR branch). Assessing successful 
tumor cleaning up in the FLR before 
surgical stage 2. Ruling out thrombosis 
of the portal braches, hepatic veins and 
inferior vena cava. Identifying tumor 
relapse
Delayed (3-5 min) Upper or whole 
abdomen, 
depending on 
findings on 
previous scans
Assessing lesions’ enhancement 
pattern for the purpose of 
identification/characterization. 
Identifying additional findings 
potentially contraindicating ALPSS 
(e.g., peritoneal carcinosis). This 
phase is not mandatory
Assessing venous bleeding. This phase in 
not mandatory
Table 1  Institutional multiphasic multidetector computed tomography protocol for evaluating associating liver partition and portal 
vein ligation for staged hepatectomy  patients before and after surgery (LightSpeed HD, General Electrics, Milwaukee, United 
States)
MIP: Maximum intensity projection; FLR: Future liver remnant; ALPPS: Associating liver partition and portal vein ligation for staged hepatectomy; HCC: 
Hepatocellular carcinoma.
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evaluated, including large, inoperable primary cancer 
on other sites, as well as portal hypertension (including 
splenomegaly and venous collaterals).
The final key step in preoperative imaging is liver 
volumetry (LV) of the FLR and the whole liver. FLR 
volume should be calculated by excluding major vessels 
and FLLs, in order to obtain a reasonable estimate of 
final viable liver tissue supporting liver function. FLR 
should be no lower than 25%-30% of preoperative liver 
volume in patients with normal liver function, and no 
lower than 40% in patients with underlying chronic liver 
disease or liver dysfunction (including the effects of 
chemotherapy)[7,23,50-52]. Many dedicated liver volumetry 
software are currently available, most times implemented 
in the picture archive and communication systems used 
for routine image analysis. In our Institution, abdominal 
radiologists perform LV together with liver surgeons, with 
the objective of reliable volumes definition according to 
Sequence Weightening Acquisition plane Technical clues Rationale in the preoperative 
phase
Rationale in the postoperative 
phase
Half fourier acquisition 
single-shot turbo spin echo/
single shot fast spin echo
T2 Coronal, transverse - Ruling out signs of chronic liver 
disease, including splenomegaly 
and/or ascites. Detection 
of parenchymal low signal 
intensity in iron accumulation
Detection of perihepatic/
abdominal collection and/or 
ascites
GE in-phase/out of-phase T1 Transverse Dual echo, breath 
hold sequence with 
slice thickness 6 mm
Characterization of fat-
containing lesions. Detection of 
signal intensity patterns of liver 
steatosis or hemochromatosis
Evaluation of the 
postoperative status of liver 
parenchyma. Characterization 
of tumor recurrence
MRCP T2 Radial coronal 
acquisition (2D) or 
oblique coronal (3D)
2D and/or 3D 
technique 
Evaluation of anatomic variants 
complicating or contraindicating 
surgery. Assessing the 
Bismuth category of hilar 
cholangiocarcinoma
Assessment of biliary 
strictures (site, extent) and 
biliary dilation upstream
Dynamic study with fat 
saturated 3D GE 
T1 Transverse Thin slice thickness 
(3 mm). Baseline 
acquisition followed 
by early arterial, late 
arterial, venous and 
delayed phases
Detection and characterization 
of liver lesions
Detection and characterization 
of parenchymal abnormalities, 
including tumor recurrence
Single-shot echoplanar 
imaging
Diffusion Transverse b values 50 and 400 
and 800 s/mm2 (1.5T) 
or 50 and 800 and 
1200 s/mm2 (3.0T). 
Nominal acquisition 
time about 3 min 
(1.5T) and 4 min (3T)
Detection and characterization 
of smaller lesions (< 1 cm in size)
Detection of parenchymal/
periportal edema. Detection 
and characterization of smaller 
lesions (< 1 cm in size)
Fat saturated Turbo spin 
echo
T2 Transverse Respiratory 
triggered, with slice 
thickness 6 mm. 
Nominal acquisition 
time 1.50 min
Detection and characterization 
of liver lesions.
Detection of parenchymal/
periportal edema. Detection 
and characterization of 
liver lesions. Assessment of 
collections
GE in-phase/out of-phase T1 Transverse Same sequence as 
(2), acquired in the 
hepatobiliary phase 
(15-20 min after 
contrast injection)
Detection and characterization 
of liver lesions
Detection and characterization 
of liver abnormalities
Fat saturated 3D GE T1 Transverse Same sequence as 
(4), with modified 
flip angle (35°) to 
increase lesion-
to-parenchyma 
conspicuity. 
Acquired in the 
hepatobiliary phase
Contrast-enhanced T1 Oblique coronal Thin-slice (1 mm) fat 
saturated 3D fast low 
angle shot (FLASH) 
sequence acquired
Functional evaluation of biliary 
obstruction (if present)
Detection of active bile 
leakage. Functional assessment 
of bile duct strictures and 
patency of bilioenteric 
anastomosis
MRCP
Table 2  Institutional magnetic resonance imaging protocol with i.v.  administration gadoxetic acid (0.025 mmol/kg at an injection 
rate of 1 mL/s) for evaluating associating liver partition and portal vein ligation for staged hepatectomy patients before and after 
surgery
GE: Gradient echo; MRCP: Magnetic resonance cholangiopancreatography.
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the intended lines of resection.
Imaging after surgical stage 1
Goals: In uncomplicated patients, post-stage 1 imaging 
is performed at the time adequate FLR hypertrophy 
is expectedly achieved (about 6-9 d from surgery)[7]. 
Cross-sectional imaging is mandatory to calculate the 
increase in volume of the FLR using LV (Figure 4), to 
confirm tumor-free status of the FLR, and to verify the 
expected changes in the DH (atrophy and persistent 
portal devascularization).
In the case of US and/or clinical suspicion, MDCT or 
MRI must be anticipated to guarantee early assessment 
and intervention. Cross-sectional imaging is also of help 
in ruling-out surgical complications or insufficient FLR 
volume as a cause for postoperative liver failure.
Normal findings: Normal hypertrophic FLR is represented 
in Figure 4. Enlargement can be easily appreciated 
on transverse and reformatted 2D images, though 
precise estimation should be always performed on 3D 
reconstructions obtained with LV. The magnitude of 
expected FLR increase ranges between 61% and 93% 
compared to the baseline volume[50]. In our center, a 
minimum increase of 40% is needed for completing the 
procedure. It is of paramount importance to distinguish 
between true parenchymal hypertrophy and liver enlarge-
ment from postoperative liver edema or congestion. 
Measurement of Hounsfield units (HU) on MDCT can be 
of help in the distinction, since edematous parenchyma 
shows significantly lower attenuation compared to 
unaffected liver[20]. In rare cases in which doubts persist, 
MRI can be of help in differential diagnosis by showing 
parenchymal and/or prominent periportal edema.
FLR and DH are often surrounded by a thin rim of 
free fluid, which is usually more prominent around the 
DH when the endobag is on site. Of note, thin walls make 
the endobag usually not directly visible on images. Small 
air bubbles are frequently mixed within the perihepatic 
fluid, sometimes at a larger extent along the line of 
hepatectomy (Figure 5). It is crucial not to misdiagnose 
this normal finding with an infected collection, which 
is usually larger, lenticular or round in shape and some-
times well-encapsulated on contrast-enhanced images. 
Mild periportal edema is commonly present as a thin 
hypodense (on MDCT) or hyperintense (on T2-weighted 
MRI images) halo surrounding the intrahepatic portal 
branches.
Except for the portal branches of the DH, the vascular 
supply to the liver is preserved, with the hepatic artery 
for the DH appearing slightly hypertrophic compared 
to the baseline examination to compensate for portal 
occlusion. No biliary dilation should be observed, in both 
the DH and FLR.
Main complications: Postoperative complications of 
ALPPS include bleeding, bile leakage, fluid or bile collections, 
A B C
Figure 3  Radiologists should carefully report the number, size, and location of individual lesions, as well as their relationship with surgically relevant 
anatomic structures, including the hepatic artery, main portal branches, hepatic veins, and first- to second-order biliary branches. A: Preoperative 
assessment with computed tomography in a 64 male years old patient showing colorectal metastases on the right hepatic lobe (red arrow). Right trisectionectomy 
associating liver partition and portal vein ligation for staged hepatectomy was planned; B: One small satellite lesion was found on the left side of the middle hepatic 
vein (arrowhead), indicating the need for future liver remnant clean-up during stage 1; C: No vascular involvement was shown, as exemplified by patent main portal 
trunk and intrahepatic branches (green triangle), except for infiltration of the middle hepatic vein (double green triangle). Based on this finding, a wide free margin 
between the line of resection and the middle hepatic vein was obtained.
A B
Figure 4  Evolution of the future liver remnant (liver segments 2 + 3) 
before (A) and after stage 1 surgery (B). Future liver remnant remnant almost 
doubled in volume (from 280 cm3 to 468 cm3), showing clear enlargement on 
2D images and volume rendering reconstructions.
Zerial M et al . Cross-sectional imaging of ALPPS
740 June 8, 2017|Volume 9|Issue 16|WJH|www.wjgnet.com
biliary fistula, cholangitis, portal vein thrombosis (PVT), 
hepatic vein and hepatic arterial thrombosis, hepatic 
dysfunction, liver failure, persistent postoperative ascites, 
pleural effusion, prolonged ileus, coagulation disorders, 
cardiovascular, respiratory, and renal system dysfunction, 
encephalopathy and infection[5,53]. Clinical presentation is 
often challenging, since patient’s signs and symptoms tend 
to be non-specific. They include fever, abdominal pain, 
jaundice, ascites, pleural effusion, abnormal liver tests and 
bleeding or bile within the drains[54]. Post-hepatectomy 
liver failure has been specifically defined according to 
so called 50-50 criteria (prothrombin time < 50% and 
total serum bilirubin > 50 mmol/L on postoperative day 
5 or after)[55]. Imaging is recommended in symptomatic 
patients to rule-out vascular, biliary or parenchymal causes. 
The most common ALPPS complications encountered 
on abdominal cross-sectional imaging are collections, 
hemorrhage and vascular thrombosis.
Collections are represented by hematoma (up to 
50% of cases), biloma (25%) and infected collections 
(25%)[56]. Collections tend to origin from the resection 
surfaces, i.e., (assuming right trisectionectomy) in the 
subphrenic space if originating from the FLR, and within 
the endobag if originating from DH. Small bilomas and/or 
transient hematomas are common during the first post-
operative days, being rapidly reabsorbed or showing 
no tendency to increase. On the contrary, collections 
with large size or increasing in volume over a few days 
should be regarded as pathological (Figure 6). Bilomas 
are virtually indistinguishable from serous collections on 
MDCT, since they present homogeneous fluid content 
(< 30 HU) without contrast-enhancement. Active biliary 
leakage can be shown on gadoxetic acid-enhanced 
MRCP because of contrast extravasation from bile ducts 
or liver surface into the collection[57,58]. Early diagnosis of 
biliary leakage is important to prevent biliary sepsis. In 
this case, stage 2 might be anticipated before the FLR is 
sufficiently hypertrophied, even if at risk of subsequent 
insufficient liver function. Hematomas usually show more 
heterogeneous content than bilomas, with mixed internal 
areas of low and high attenuation (> 30 HU) on MDCT 
reflecting the presence of fibrin septa and clots. On MRI, 
bilomas appears as fluid collections with hypointensity on 
T1-weighted images and hyperintensity on T2-weightd 
images, whereas hematomas show typical hyperintensity 
on T1-weighted fat suppressed images. Treatment 
options for collections include drainage under sonographic 
or MDCT guidance, as well as surgical toilette in more 
extensive cases[3,59]. Infected collections typically show 
small air bubbles from anaerobic bacteria, and may be 
surrounded by thickened contrast-enhancing walls of 
peripheral inflammatory tissue.
A B C
Figure 5  Normal findings on computed tomography after stage 1 surgery on transverse (A) and coronally-reformatted images (B), as well as volume 
rendering 3D reconstruction (C) (right trisectionectomy associating liver partition and portal vein ligation for staged hepatectomy). A thin rim of free fluid 
with air bubbles is visible along the surface of diseased hemiliver (right liver lobe), suggesting its accumulation within the plastic bag (green triangle on A and B). A 
similar finding can be appreciated along the line of transection. Mild periportal edema (yellow arrowhead in A), thin hypodense bands along the edges of surgical 
resection (arrows on both A and B) and drains (blue arrowheads) are visible. Main right portal branch was ligated and transected (thick arrow in C). Hepatic artery 
branches are patent (C), including right hepatic artery, which shows mild hypertophy (arrowhead), and left hepatic artery (thin arrow).
A B
Figure 6  Biloma in a 49-year-old female patient who underwent 
associating liver partition and portal vein ligation for staged hepatectomy 
because of peripheral cholangiocarcinoma of the right liver lobe. A: 
Computed tomography was performed because of bile flowing from the right 
drainage (blue triangle). The examination confirmed a large fluid collection 
beneath the DH (red triangle), which distended the plastic bag (red arrows). 
Biloma was removed with the DH during stage 2 surgery, resolving the biliary 
leakage originating from right transection surface; B: Normal position of the 
two drains on volume rendering reconstruction. Left drain has a vertical course 
along the line of transection up to the inferior margin of the diaphragm (arrow). 
Right drain has an horizontal course beneath DH (triangle), with its his placed 
within the plastic bag, in order to drain collections. DH: Diseased hemiliver.
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Postoperative hemorrhage generally arises within 48 h 
from intervention, commonly originating from the resection 
margins (e.g., because of an arterial branch truncation or 
congestion of the hepatic vein due to stenosis or ligation), 
incomplete intraoperative hemostasis or dehiscence of 
vascular sutures[3]. MDCT with angiographic phase should 
be promptly performed to identify the site of bleeding 
and guide embolization or surgery.
The most threatening vascular complication after 
stage 1 is portal thrombosis. This rare condition may 
affect the portal trunk and/or the FLR branch, thus 
affecting the hypertrophy process. Not surprisingly, 
patients showing extensive PVT are at high risk of 
liver failure and death[7,26,28]. Color Doppler US has a 
primary role in detecting thrombosis. Similarly to other 
postoperative scenarios[41], thrombosis manifests with 
absent flow, with our without direct demonstration of an 
intraluminal echogenic thrombus on B-mode. Although 
no specific data on ALPPS have been reported, to our 
knowledge, contrast-enhanced US is supposedly of 
help in confirming absent contrast arrival in thrombotic 
vessels[41]. Post-contrast MDCT and/or MRI acquired 
on venous and delayed phases are useful to confirm 
color Doppler findings, as well as to map the extent of 
thrombosis (portal trunk and/or FLR main branch and/or 
intrahepatic branches) and the degree of occlusion (partial 
or complete filling defects). Contrast enhancement of 
vascular walls is an additional findings of thrombosis, 
likely representing contrast engorgement within dilated 
vasa vasorum[60,61]. Partial thrombosis may benefit from 
medical therapy, whereas complete thrombosis requires 
thrombolysis.
Imaging after surgical stage 2
Goals: Early cross-sectional imaging is usually not required 
in the case of an uncomplicated clinical course. Chest 
X-ray and abdominal US with color Doppler interrogation 
of major vessels are usually sufficient to monitor the 
patient in the first weeks after the intervention. MDCT 
and/or MRI should be ordered in the case of suspicious 
complications and/or inconclusive findings on US. On the 
contrary, cross-sectional imaging has a major role in the 
delayed postoperative period, mainly in assessing tumor 
recurrence and/or late complications with or without prior 
US.
Recommended imaging follow-up includes US and 
MDCT or MRI scan after 3 and 6-12 mo from surgery, 
respectively[54]. However, there is no definite schedule 
for imaging controls, which should be tailored to patients 
according to the type and extent of the operated tumor, 
concomitant chemotherapy and history of major com-
plications after surgical stage 1 and/or 2. MRI is reserved 
to cases of suspicious biliary complications or for chara-
cterizing ambiguous CT findings.
Normal findings: Asymptomatic, small amounts of intra-
abdominal air or small fluid collections are common findings 
in the postoperative phase. Air is usually reabsorbed early, 
whereas collections can persist up to two months after 
surgery[56]. Another frequent finding is represented by a 
hypoattenuating linear band adjacent to liver raw surface 
(about 30%-50% of cases), which has been related to 
the effects of parenchymal devascularization or bile/blood 
accumulation[56]. No vascular or biliary abnormalities 
should be found (Figure 7).
Of note, transitory splenic enlargement is commonly 
encountered within 6 mo from hepatectomy. The degree 
of splenomegaly is generally proportional to the volume 
of liver resection, with average increase in splenic volume 
of about 40% compared to the preoperative period[62-64].
Main complications: Complications after stage 2 may 
be classified into early and late, depending on the onset 
from surgery. Early complications occur within a few 
weeks from stage 2, and manifest with a clinical and 
radiological spectrum similar to that following stage 1 
surgery. Thus, hematomas/bilomas (Figure 8), bleeding, 
vascular thrombosis and pleural effusion represent main 
expected findings, presenting as described above. Late 
complications are stage 2 specific, and tend to occur 
from 3 to about 6 mo after this surgical step. The most 
frequent and relevant ones are tumor recurrence and 
biliary complications. The treatment of late complications 
may be challenging, especially if further surgery is 
A B C
Figure 7  Bilioenteric anastomosis between the jejuneum and biliary branches for hepatic segments 2-3 after right trisectionectomy associating liver 
partition and portal vein ligation for staged hepatectomy performed for hilar colangiocarcinoma showing. A, B: Magnetic resonance imaging single-shot turbo 
spin echo T2 weighted images acquired on transverse (A) and coronal planes (B) show absence of biliary dilatation; C: This finding was confirmed on thick maximum 
intensity projection coronally-reformatted image acquired on the hepatobiliary phase after gadoxetic acid administration, demonstrating regular flow of hyperintense 
bile.
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needed. Indeed, additional interventions may in turn 
increase the risk of morbidity (Figure 9).
The International ALPSS registry[27] reported disease-
free survival of 73% and 59% at 1 and 2 years after 
ALPSS, respectively, with median survival of 14 mo. 
Recurrence appears with MDCT and/or MRI signs of the 
original tumor, though recurrence can manifest with 
pleomorphic, nonspecific appearance in our experience 
(Figure 9). Suspicious solid lesions should be regarded 
as tumor recurrence, regardless of the fact they mimic 
preoperative lesions or not.
Late biliary complications include stricture and fistula. 
Because of the recent introduction of ALPSS, it is difficult 
to quantify the prevalence of these complications, which 
are generally rare in experienced centers. Strictures are 
multifactorial in origin, having been related to mechanical 
stress from FLR enlargement and rotation, as well as 
to iatrogenic causes (inaccurately placed clips, injury, 
periductal bile leakage and ischemia due to injured FLR 
hepatic artery)[65,66].
MRCP is the elective tool to assess the site of obstruction, 
which appears as a focal zone of absent signal on fluid-
A B
Figure 8  Intrabdominal collection 9 d after stage 2 surgery in a 49-year-old female patient with fever and altered liver function tests. A: Large, encapsulated 
collection with fluid-air level was shown after diseased hemiliver removal, with mild parietal enhancement (arrow). Part of the collection surrounded liver segment I (arrow 
head); B: Bilateral pleural effusion coexisted. 
A B
C D E
Figure 9  Recurrence appears with multidetector computed tomography and/or magnetic resonance imaging signs of the original tumor, though 
recurrence can manifest with pleomorphic, nonspecific appearance in our experience. A, B: Multifocal recurrent cholangiocarcinoma presenting 16 mo after 
right trisectionectomy associating liver partition and portal vein ligation for staged hepatectomy. Lesions showed atypical persistently hypovascular appearance 
on dynamic contrast-enhanced multidetector computed tomography; C-E: Wedge resection of recurrences was complicated by biliary leakage, as shown on 
percutaneous transhepatic cholangiography (arrow in C), treated by positioning a drainage within the biloma and a biliary stent graft, as shown on maximum intensity 
projection reconstruction in D and oblique sagittal reformation in E.
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sensitive images, as well as the degree of proximal biliary 
dilation[42]. Strictures of the bilioenteric anastomosis 
should be evaluated with gadoxetic acid-based MRCP, 
which shows lack of contrast flow from the biliary tree 
to the anastomotic bowel loop[65,67]. This technique is of 
help also in identifying the site of bile extravasation when 
chronic biliary fistula is suspected. Similarly to other 
clinical scenarios[42], MRCP is electively ordered in patients 
with low pre-test probability of biliary complications, 
since a negative result is reliable enough to avoid invasive 
procedures of direct cholangiography. On the other hand, 
MRCP is effective also in patients with high pre-test 
probability of disease, since it provides a panoramic and 
detailed representation of pathological findings, i.e., an 
accurate road-map for planning the most appropriate 
interventional approach. Most bilomas and strictures 
are treated with endoscopic sphincterotomy and balloon 
dilation followed by endoprothesis placement.
An overall view of normal postoperative findings 
and complications after both surgical stages 1 and 2 is 
provided in Table 3.
CONCLUSION
ALPSS is an increasingly popular two-stage hepa-
tectomy technique associated with portal ligation aimed 
to obtain rapid and adequate FLR hypertrophy, thus 
extending operability in patients with massive primary 
or secondary neoplastic liver involvement.
Cross-sectional imaging, especially MDCT, plays a 
key role in planning ALPPS procedure and monitoring 
different surgical stages. In particular, MDCT is the 
main instrument to provide liver volumetry, which is of 
special importance in assessing technique feasibility and 
assessing variation in volume of the FLR between surgical 
stages. MDCT also confirm a clinical or sonographic 
suspicion of complications, including collections, bilomas, 
hematomas, post-surgical bleeding, PVT, and tumor 
recurrence. MRI should be used as a problem-solving 
tool in both preoperative and postoperative phases, 
whereas MRCP has an elective role in assessing biliary 
complications.
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